3isy

From Proteopedia
Jump to navigation Jump to search

Crystal structure of an intracellular proteinase inhibitor (ipi, bsu11130) from bacillus subtilis at 2.61 A resolutionCrystal structure of an intracellular proteinase inhibitor (ipi, bsu11130) from bacillus subtilis at 2.61 A resolution

Structural highlights

3isy is a 1 chain structure with sequence from Bacillus subtilis. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
Method:X-ray diffraction, Resolution 2.61Å
Ligands:,
Resources:FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT, TOPSAN

Function

IPI_BACSU Directly regulates the major intracellular proteinase (ISP-1) activity in vivo. Inhibits ISP-1 in the early stages of sporulation. It may be then inactivated by a membrane-bound proteinase.

Evolutionary Conservation

Check, as determined by ConSurfDB. You may read the explanation of the method and the full data available from ConSurf.

Publication Abstract from PubMed

We report the crystal structure solution of the Intracellular Protease Inhibitor (IPI) protein from Bacillus subtilis, which has been reported to be an inhibitor of the intracellular subtilisin Isp1 from the same organism. The structure of IPI is a variant of the all-beta, immunoglobulin (Ig) fold. It is possible that IPI is important for protein-protein interactions, of which inhibition of Isp1 is one. The intracellular nature of ISP is questioned, because an alternative ATG codon in the ipi gene would produce a protein with an N-terminal extension containing a signal peptide. It is possible that alternative initiation exists, producing either an intracellular inhibitor or a secreted form that may be associated with the cell surface. Homologues of the IPI protein from other species are multi-domain proteins, containing signal peptides and domains also associated with the bacterial cell-surface. The cysteine peptidase inhibitors chagasin and amoebiasin also have Ig-like folds, but their topology differs significantly from that of IPI, and they share no recent common ancestor. A model of IPI docked to Isp1 shows similarities to other subtilisin:inhibitor complexes, particularly where the inhibitor interacts with the peptidase active site.

The first structure in a family of peptidase inhibitors reveals an unusual Ig-like fold.,Rigden DJ, Xu Q, Chang Y, Eberhardt RY, Finn RD, Rawlings ND F1000Res. 2013 Jul 10;2:154. doi: 10.12688/f1000research.2-154.v2. eCollection, 2013. PMID:24555072[1]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

References

  1. Rigden DJ, Xu Q, Chang Y, Eberhardt RY, Finn RD, Rawlings ND. The first structure in a family of peptidase inhibitors reveals an unusual Ig-like fold. F1000Res. 2013 Jul 10;2:154. doi: 10.12688/f1000research.2-154.v2. eCollection, 2013. PMID:24555072 doi:http://dx.doi.org/10.12688/f1000research.2-154.v2

3isy, resolution 2.61Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA